Thomas Patrick Joyce, Jr. Sells 14,454 Shares of Danaher Co. (DHR) Stock
Danaher Co. (NYSE:DHR) insider Thomas Patrick Joyce, Jr. sold 14,454 shares of Danaher stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $132.79, for a total transaction of $1,919,346.66. Following the completion of the transaction, the insider now owns 200,479 shares in the company, valued at approximately $26,621,606.41. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Shares of DHR stock traded down $0.78 during mid-day trading on Monday, reaching $130.32. The stock had a trading volume of 1,941,535 shares, compared to its average volume of 2,829,014. Danaher Co. has a 52-week low of $94.59 and a 52-week high of $134.67. The stock has a market capitalization of $93.86 billion, a price-to-earnings ratio of 28.83, a PEG ratio of 2.53 and a beta of 1.02. The company has a current ratio of 2.18, a quick ratio of 1.74 and a debt-to-equity ratio of 0.32.
Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, April 18th. The conglomerate reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.01 by $0.06. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The firm had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.80 billion. During the same quarter in the previous year, the company earned $0.99 earnings per share. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. Equities analysts predict that Danaher Co. will post 4.77 EPS for the current year.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. CX Institutional increased its position in shares of Danaher by 188.7% during the first quarter. CX Institutional now owns 205 shares of the conglomerate’s stock valued at $27,000 after buying an additional 134 shares during the period. Laurel Wealth Advisors LLC purchased a new position in shares of Danaher during the fourth quarter valued at approximately $27,000. Lenox Wealth Management Inc. purchased a new position in shares of Danaher during the first quarter valued at approximately $40,000. Hanson McClain Inc. raised its holdings in shares of Danaher by 852.9% during the fourth quarter. Hanson McClain Inc. now owns 324 shares of the conglomerate’s stock valued at $33,000 after purchasing an additional 290 shares during the last quarter. Finally, Executive Wealth Management LLC purchased a new position in shares of Danaher during the fourth quarter valued at approximately $39,000. Institutional investors own 76.98% of the company’s stock.
DHR has been the topic of a number of analyst reports. Zacks Investment Research cut shares of Danaher from a “buy” rating to a “hold” rating in a research report on Tuesday, April 23rd. Deutsche Bank lifted their target price on shares of Danaher to $130.00 and gave the stock a “buy” rating in a research report on Tuesday, February 26th. Jefferies Financial Group lifted their target price on shares of Danaher to $140.00 and gave the stock a “buy” rating in a research report on Tuesday, February 26th. UBS Group lifted their target price on shares of Danaher from $125.00 to $144.00 and gave the stock a “buy” rating in a research report on Tuesday, February 26th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $141.00 target price (up previously from $138.00) on shares of Danaher in a research report on Wednesday, April 17th. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Danaher presently has a consensus rating of “Buy” and a consensus target price of $131.75.
TRADEMARK VIOLATION WARNING: This article was originally published by Daily Political and is the property of of Daily Political. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at https://www.dailypolitical.com/2019/05/20/thomas-patrick-joyce-jr-sells-14454-shares-of-danaher-co-dhr-stock.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Story: What are defining characteristics of a correction?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.